Recommended maximum time intervals and reported median delays in specialist consultation and treatment (in days)
Author | GP referral to specialist consultation | Consultation to surgery | Waiting list for surgery | Diagnosis to treatment | Decision-to-treat to treatment other than surgery | GP referral to initial treatment | Comment |
Recommendations | |||||||
BTS guideline1 | 7 | 56 | 28 | 7–28¶ | |||
NHS Cancer Plan2 | 14 | 31 | 62 | ||||
RAND Corporation3 | 42 | ||||||
USA | |||||||
Dransfield et al26 | 104† | Lung mass clinic | |||||
Riedel et al31 | 21† | Multidisciplinary clinic | |||||
23†§ | Conventional referrals | ||||||
Canada | |||||||
Bardell et al34 | 39† | Surgical patients | |||||
Johnston et al36 | 42 (IQR 28–77) | 14 (IQR 7–28) | Radiotherapy patients | ||||
Simunovic et al35 | Year 1993: 25† | Surgical patients | |||||
Year 2000: 34† | |||||||
Liberman et al21 | 68† | 23† | 52† | Surgical patients | |||
UK and Ireland | |||||||
Bozcuk et al10 | 11† | 48† | |||||
Campbell et al52 | 34† | ||||||
Comber et al19 | 7 (IQR 3–17) | 54 (IQR 28–100) | |||||
Devbhandari et al45 | 1 (0–5) | 60 (IQR 44–85) | |||||
Dische et al53 | 35 (IQR 21–63) | 7 (IQR 7–21) | Radiotherapy patients | ||||
Kesson et al54 | 63† | ||||||
Lee et al50 | 17 (0–92) | Surgical patients | |||||
Leo et al44 | 22† | 16† (chemotherapy) | |||||
27† (radiotherapy) | |||||||
Lewis et al29 | 7 (0–124)‡ | 37 (2–228)‡ | |||||
9 (0–98) | 42 (0–239) | ||||||
Melling et al41 | 7† | 28† | |||||
Neal et al20 | 10 (IQR 6–13) | ||||||
Spurgeon et al55 | 12 (IQR 7–22) | 47 (IQR 28–77) | |||||
Urgent: 7 (IQR 3–13) | Urgent: 39 (IQR 21–61) | ||||||
European Union* | |||||||
Aragoneses et al11 | 35 (1–154) | Surgical patients | |||||
Christensen et al56 | 60† | Surgical patients | |||||
Koyi et al39 | 31† | ||||||
Salomaa et al6 | 8† | 15† | |||||
Other countries | |||||||
Annakaya et al17 | 12.5 (10–25) | ||||||
Ozlu et al38 | 35 (2–123) | 17.5 (0–206) | |||||
Range of medians | (1–12) | (31–104) | (17–60) | (12.5–52) | (7–27) | (34–60) |
Values in parentheses are ranges unless otherwise noted.
*Excluding UK and Ireland. †Range or IQR not reported. ‡Before and after intervention. §Not a statistically significant difference. ¶Seven working days for chemotherapy, 14 days for palliative radiotherapy and 28 days for radical radiotherapy.
BTS, British Thoracic Society; GP, general practitioner; IQR, interquartile range; NHS, National Health Service.